nct_id: NCT06436976
age: Adults
cancer_center_accrual_goal_upper: 0
curated_on: '2024-05-31'
study_start_date: '2024-03-01'
study_completion_date: null
data_table4: Interventional
drug_list:
  drug:
  - drug_name: 'Drug: LT-002 (Lactobacillus reuteri ATG-F4'
long_title: The Effect of Probiotics ATG-F4 in Cancer Patients
last_updated: '2024-05-31'
management_group_list:
  management_group:
  - is_primary: Y
    management_group_name: Group1
oncology_group_list:
  oncology_group:
  - group_name: Group1
    is_primary: N
phase: PHASE2
principal_investigator: Hyewon Ryu, Professor
principal_investigator_institution: Department of Hematology Oncology
program_area_list:
  program_area:
  - is_primary: Y
    program_area_name: Program1
protocol_id: 0
protocol_ids: []
protocol_no: ''
protocol_target_accrual: 30
protocol_type: INTERVENTIONAL
prior_treatment_requirements:
- 'Inclusion Criteria:'
- '* Patients diagnosed with advanced colorectal cancer or pancreatic cancer who are
  undergoing treatment with Oxaliplatin-based chemotherapy at Chungnam National University
  Hospital, including both newly diagnosed and recurrent cases.'
- '* Aged 19 years or older.'
- '* Eastern Cooperative Oncology Group (ECOG) performance status score of 0-2 points.'
- '* Expected life expectancy of at least 3 months.'
- '* Ability to understand the requirements of the clinical trial and willingness
  to sign the informed consent form.'
- 'Exclude - Exclusion Criteria:'
- Exclude - * Presence of known brain metastases.
- Exclude - * Malignant bowel obstruction requiring surgical intervention.
- Exclude - * Uncontrolled, active infections, symptomatic congestive heart failure,
  unstable angina, cardiac arrhythmias, or any psychiatric/social conditions that
  may limit compliance with the study requirements.
- Exclude - * Partial or complete intestinal obstruction.
- Exclude - * Pregnant or lactating women.
- Exclude - * Use of antibiotics, antifungals, or antiviral agents on more than one
  occasion within the past month.
- Exclude - * Consumption of probiotics products or fermented milk more than twice
  within the past month.
- Exclude - * Patients with neurological or psychiatric disorders.
short_title: The Effect of Probiotics ATG-F4 in Cancer Patients
site_list:
  site: []
sponsor_list:
  sponsor:
  - is_principal_sponsor: Y
    sponsor_name: Chungnam National University Hospital
    sponsor_protocol_no: ''
    sponsor_roles: sponsor
staff_list:
  protocol_staff: []
status: open to accrual
summary: Patients with advanced colorectal cancer or pancreatic cancer who are receiving
  oxaliplatin-based chemotherapy will be included. The research participants in this
  study will consume probiotics along with safety and anti-cancer agent side effect-related
  questionnaires, blood, and fecal sample collection for up to 12 weeks from the date
  of registration. The total duration of participation for research subjects is 12
  weeks.
treatment_list:
  step:
  - step_internal_id: 111
    step_code: '1'
    step_type: Registration
    arm:
    - arm_code: LT-002 (Lactobacillus reuteri ATG-F4) arm
      arm_internal_id: 0
      arm_description: The group that will be consuming probiotics (LT-002 (Lactobacillus
        reuteri ATG-F4)) for 12 weeks. The subjects will take a daily intake of 4
        x 10\^10 colony forming unit (CFU) of LT-002.
      arm_suspended: N
      dose_level:
      - level_code: '0'
        level_description: 'Drug: LT-002 (Lactobacillus reuteri ATG-F4'
        level_internal_id: 0
        level_suspended: N
    match:
    - and:
      - or:
        - clinical:
            oncotree_primary_diagnosis: Pancreatoblastoma
        - clinical:
            oncotree_primary_diagnosis: Adenosquamous Carcinoma of the Pancreas
        - clinical:
            oncotree_primary_diagnosis: Undifferentiated Carcinoma of the Pancreas
        - clinical:
            oncotree_primary_diagnosis: Solid Pseudopapillary Neoplasm of the Pancreas
        - clinical:
            oncotree_primary_diagnosis: Pancreatic Neuroendocrine Tumor
        - clinical:
            oncotree_primary_diagnosis: Pancreatic Adenocarcinoma
        - clinical:
            oncotree_primary_diagnosis: Medullary Carcinoma of the Colon
        - clinical:
            oncotree_primary_diagnosis: Acinar Cell Carcinoma of the Pancreas
        - clinical:
            oncotree_primary_diagnosis: Cystic Tumor of the Pancreas
        - clinical:
            oncotree_primary_diagnosis: Colorectal Adenocarcinoma
        - clinical:
            oncotree_primary_diagnosis: Pancreatic Neuroendocrine Carcinoma
      - clinical:
          age_numerical: '>=19'
          disease_status:
          - Advanced
          - Recurrent
